← Eichor
Study identifier: NCT06045013 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone in Carpal Tunnel Syndrome

Condition: Carpal Tunnel Syndrome  ·  Sponsor: General and Veteran Hospital Croatian Pride Knin

PhasePhase 3
Planned participants70
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this prospective, randomized, double-blinded, head-to-head comparative study is to compare the efficacy of ultrasound-guided 4 ml 5% dextrose perineural injection versus 3 ml 5% dextrose with 1 ml 40 mg/ml methylprednisolone perineural injection in patients with carpal tunnel syndrome (CTS). The main questions it aims to answer are: Is there a difference in efficacy between interventions regarding 1. pain alleviation, 2. improvement in symptoms severity and functional status, 3. improvement in grip strength, 4. size of median nerve cross-sectional area, and 5. improvement in quality of life during the six-month post-intervention follow-up period?

This description comes directly from the study's public registry record.

Talk to the study team

Igor Begović, MD  ·  +385911748137  ·  igorbegovic2@gmail.com

Nadica Laktašić Žerjavić, Prof,MD,PhD.  ·  +385915606957  ·  nadica_laktasic@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

General and Veteran Hospital "Croatian Pride" KninKnin, CroatiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06045013